Two Pfizer doses give 95 per cent protection against Covid-19 infection, illness and death: first nationwide study
Two doses of a Covid-19 vaccine developed by Pfizer and BioNTech can provide more than 95 per cent protection against infection, severe illness and death, according to the first nation-wide data from Israel.
A single dose of the jab, meanwhile, is associated with 58 per cent protection against infection, 76 per cent against hospital admission, and 77 per cent against death, research published in the journal The Lancet suggests.
First of its kind
The findings are based on a national-level assessment of the effectiveness of the vaccine and is thought to be the first observational evaluation of its kind.
Minister Zweli Mkhiza says he would consult the Ministerial Advisory Committee on other measures regarding travellers from countries that have other variants of Covid-19.
Irish scientist optimistic alpaca can be ally in in fight against Covid-19 Researcher based in South Africa finds animal’s antibodies show signs of neutralising variants
Mon, May 3, 2021, 01:00
Bill Corcoran Cape Town Listen now 4:44
Two alpacas: “We believe our alpaca antibodies would be best administered using an inhaler as they are 10 times smaller than human antibodies,” says Dr Peter Durcan.
Your Web Browser may be out of date. If you are using Internet Explorer 9, 10 or 11 our Audio player will not work properly.
The South American alpaca may seem like an unlikely ally in humanity’s fight to overcome the coronavirus, but an Irish scientist believes the mammal is key to developing an effective treatment against the disease.
Irish scientist in Cape Town optimistic about finding cure for Covid-19 irishtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from irishtimes.com Daily Mail and Mail on Sunday newspapers.
Use at least 8 characters, an uppercase and a lowercase letter, and a number or symbol.
Please ensure your password has at least 8 characters, an uppercase and a lowercase letter, and a number or symbol.
By clicking Create Account and Subscribe you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice.
Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email address with any third parties. You can unsubscribe whenever you want.
By clicking Sign in and Subscribe you agree to us subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice.